IMU-201 (PD1-Vaxx):
https://clinicaltrials.gov/ct2/show/NCT04432207?term=imugene&draw=2&rank=2
Estimated Enrollment: 32 participants
Estimated Study Start Date: July 2020
Estimated Primary Completion Date: December 2022
Estimated Study Completion Date: December 2022
If nothing unforeseeable gets in the way, then we should be expecting an announcement imminently.
-
- There are more pages in this discussion • 29,087 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.13M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $303.5K | 27.55M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 4401777 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 11627397 | 55 |
View Market Depth
| Last trade - 15.37pm 26/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |